Repatriation Medical Authority statement of reasons re: decision not to make statements of principles for chemically-acquired brain injury caused by mefloquine, tafenoquine or primaquine - Report 2017

Related content

• Impacts

• Foreign Affairs, Defence and Trade References Committee - Mental health of Australian Defence Force members and veterans - Report March 2016

  Impact: Public policy Impact

• Senate Inquiry Report - Use of the Quinoline antimalarial drugs mefloquine and tafenoquine in the Australian Defence Force

  Impact: Quality of life Impact, Social Impact

• An acceptable risk? The use of Lariam for Military Personnel - House of Commons Defence Committee Report. Published 24 May 2016

  Impact: Public policy Impact

• The Senate Foreign Affairs and Defence Trade References Committee. The constant battle: suicide by veterans. Report August 2017.

  Impact: Public policy Impact

• Effects of mefloquine use among Canadian veterrans. Report of the Standing Committee on Veterans Affairs, Canada.

  Impact: Public policy Impact

• Activities

• Australian Quinoline Veterans and Families Association (QVFA) (External organisation)

  Activity: Membership › Advisory position/panel/policy group/board › Community

• The Quinism Foundation (External organisation)

  Activity: Engagement and professional development › Expert/advisor › Academic

• Research Outputs

• Complex membrane channel blockade: A unifying hypothesis for the prodromal and acute neuropsychiatric sequelae resulting from exposure to the antimalarial drug Mefloquine

  Research output: Contribution to journal › Article › peer-review

• Better approach needed to detect and treat military personnel with adverse effects from mefloquine

  Research output: Contribution to journal › Article › peer-review

• Press/Media

• ABC The Round Table with Hugh Riminton - Did clinical trails of malaria drugs on Australian Defence force personnel cause lasting neurological damage?

  Press/Media: Press / Media